Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

Pyroptosis is a form of cell death that is critical for immunity. It can be induced by the canonical caspase-1 inflammasomes or by activation of caspase-4, -5 and -11 by cytosolic lipopolysaccharide. The caspases cleave gasdermin D (GSDMD) in its middle linker to release autoinhibition on its gasdermin-N domain, which executes pyroptosis via its pore-forming activity. GSDMD belongs to a gasdermin family that shares the pore-forming domain. The functions and mechanisms of activation of other gasdermins are unknown. Here we show that GSDME, which was originally identified as DFNA5 (deafness, autosomal dominant 5), can switch caspase-3-mediated apoptosis induced by TNF or chemotherapy drugs to pyroptosis. GSDME was specifically cleaved by caspase-3 in its linker, generating a GSDME-N fragment that perforates membranes and thereby induces pyroptosis. After chemotherapy, cleavage of GSDME by caspase-3 induced pyroptosis in certain GSDME-expressing cancer cells. GSDME was silenced in most cancer cells but expressed in many normal tissues. Human primary cells exhibited GSDME-dependent pyroptosis upon activation of caspase-3 by chemotherapy drugs. Gsdme−/− (also known as Dfna5−/−) mice were protected from chemotherapy-induced tissue damage and weight loss. These findings suggest that caspase-3 activation can trigger necrosis by cleaving GSDME and offer new insights into cancer chemotherapy.

[1]  H. Stahlberg,et al.  GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death , 2016, The EMBO journal.

[2]  G. Richardson,et al.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5 , 1998, Nature Genetics.

[3]  F. Shao,et al.  SnapShot: The Noncanonical Inflammasome , 2017, Cell.

[4]  Hao Xu,et al.  The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.

[5]  W. Gao,et al.  The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma , 2013, Molecular Biology Reports.

[6]  H. Nemoto,et al.  Methylation of the DFNA5 gene is frequently detected in colorectal cancer. , 2012, Anticancer research.

[7]  L. Serneels,et al.  Mice lacking Dfna5 show a diverging number of cochlear fourth row outer hair cells , 2005, Neurobiology of Disease.

[8]  S. Kearsey,et al.  A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment. , 2003, Biochimica et biophysica acta.

[9]  Dacheng Wang,et al.  Pore-forming activity and structural autoinhibition of the gasdermin family , 2016, Nature.

[10]  E. Miao,et al.  Pyroptotic cell death defends against intracellular pathogens , 2015, Immunological reviews.

[11]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[12]  M. Toyota,et al.  Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer , 2007, Cancer science.

[13]  D. Schadendorf,et al.  DFNA5 (ICERE‐1) contributes to acquired etoposide resistance in melanoma cells , 2001, FEBS letters.

[14]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[15]  M. Ohki,et al.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage , 2006, Journal of Human Genetics.

[16]  Lin Li,et al.  Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome , 2014, Nature.

[17]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[18]  V. Dixit,et al.  GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes , 2016, Proceedings of the National Academy of Sciences.

[19]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[20]  Guojun Wu,et al.  Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma , 2008, Oncogene.

[21]  N. Ben-Tal,et al.  Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy , 2006, Nature Genetics.

[22]  Arthur S Slutsky,et al.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. , 2011, American journal of respiratory cell and molecular biology.

[23]  She Chen,et al.  A Burkholderia Type VI Effector Deamidates Rho GTPases to Activate the Pyrin Inflammasome and Trigger Inflammation. , 2016, Cell host & microbe.

[24]  S. Gore,et al.  Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings , 2017, Leukemia & lymphoma.

[25]  P. Li,et al.  Inflammatory caspases are innate immune receptors for intracellular LPS , 2014, Nature.

[26]  E. Alnemri,et al.  Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death , 2017, Nature Communications.

[27]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[28]  G. Camp,et al.  DFNA5, a gene involved in hearing loss and cancer: a review. , 2012 .